As bariatric surgery has been found to be associated with reduced cancer risk in women with obesity, investigators sought to determine if the potential exists for an effect on risk for colorectal cancer.
The American Gastroenterological Association recently published new clinical practice guidelines on the management of gastric intestinal metaplasia.
This study follows up to examine the implementation of a 14-day quadruple nonbismuth concomitant regimen to treat Helicobacter pylori, as proposed by recent Guidelines and Consensus Statements.
The prevalence of H pylori infection continues to fall in the general population with only 16% of all gastric and 25% of all duodenal patients with ulcer harboring H pylori.
In-hospital mortality rates among patients requiring mechanical ventilation were not significantly different when comparing 2 stress ulcer prophylaxis strategies: proton pump inhibitors vs histamine-2 receptor blockers.
Dual therapy with vonoprazan and low-dose amoxicillin had similar efficacy to triple-drug treatment for the eradication of Helicobacter pylori.
Human host genetics of local populations may drive norovirus evolution and diversity, which may have implications for vaccine development.
Individuals who are racial or ethnic minorities and individuals who are smokers experience significantly higher risks for gastric cancer following a diagnosis of Helicobacter pylori infection.
Although the use of value pathways in oncology appeared to extend time to treatment failure, it did not appear to influence overall survival.
Researchers concluded that bariatric surgery is strongly associated with an increased risk for colon cancer, though further research may be needed to establish an association between bariatric surgery and an increased risk for rectal cancer.
In this interim analysis, PFS rates were compared in PD-L1–defined biomarker subsets of patients receiving maintenance durvalumab or capecitabine.
About 170 visitors and employees at Yosemite National Park have been hit by gastrointestinal illness, park officials say.
The FDA has approved Ayvakit (avapritinib; Blueprint Medicines Corporation), a tyrosine kinase inhibitor, for the treatment of adults with unresectable or metastatic gastrointestinal stromal tumor (GIST) harboring a platelet-derived growth factor receptor alpha (PDGFRA) exon 18 mutation, including PDGFRA D842V mutations.
Unexpectedly identifying a patient as a CDH1 carrier can lead to a “difficult conundrum” for clinicians and patients, highlighting the need for pretest counseling.
The incidence of early-onset gastric cancer has been increasing in the United States, and it seems to be distinct clinically and genetically from late-onset gastric cancer.
For patients who are overweight or obese, clinical visits are often characterized by negative interactions and dismissive advice.
Researchers sought to determine the effectiveness of nurse-led education with follow-up services in bariatric surgery patients’ weight loss and overall quality of life.
An increased risk of acute gastroenteritis during winter epidemic periods was observed in patients 45 years and older on continuous PPI therapy.
Researchers sought to evaluate the long-term effects of bariatric surgery on joint pain, physical function, and health-related quality of life.
The FDA is investigating metformin products in the US based on these reports; currently no metformin products have been recalled.